--- title: "Crinetics Pharmaceuticals (CRNX.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/CRNX.US/norm.md" symbol: "CRNX.US" name: "Crinetics Pharmaceuticals" parent: "https://longbridge.com/en/quote/CRNX.US.md" datetime: "2026-05-20T13:58:47.993Z" locales: - [en](https://longbridge.com/en/quote/CRNX.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/CRNX.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/CRNX.US/norm.md) --- # Crinetics Pharmaceuticals (CRNX.US) — Financial Reports ## Income Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -1.23 | -1.29 | -1.38 | -1.23 | -1.04 | | ROE | -45.00% | -47.60% | -46.38% | -38.14% | -30.02% | | Revenue | 10.73M | 6.16M | 143000.00 | 1.03M | 361000.00 | | Net income | -127.84M | -122.81M | -130.09M | -115.64M | -96.77M | | Operating income | -140.38M | -133.67M | -142.59M | -129.11M | -111.41M | | Gross margin | -834.24% | -1297.97% | -63161.54% | -7688.65% | -21019.11% | | Net margin | -1191.03% | -1993.43% | -90972.73% | -11216.00% | -26807.20% | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 1.40B | 1.13B | 1.20B | 1.29B | 1.36B | | Leverage | 1.09 | 1.14 | 1.12 | 1.10 | 1.09 | | BVPS | 12.16 | 10.38 | 11.34 | 12.45 | 13.41 | | Turnover | 0.0131 | 0.0060 | 0.0014 | 0.0013 | 0.0006 | | Cash & STI | 1.29B | 1.03B | 1.09B | 1.20B | 1.27B | | Inv & Rec | 3.06M | 2.02M | - | - | - | | LT assets | 53.29M | 54.79M | 55.52M | 56.57M | 55.32M | | Net debt | -1.24B | -979.35M | -1.04B | -1.15B | -1.22B | ## Cash Flow Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | -124.70M | -92.90M | -110.72M | -85.85M | -88.45M | | Investing CF | -252.36M | 57.11M | 164.81M | 37.95M | -85.96M | | Financing CF | 389.88M | 26.04M | 3.08M | 7.05M | 4.44M | | Free CF | -82.40M | -41.89M | -68.42M | -49.43M | -47.18M | | OCF coverage | -15207.68% | -20284.06% | -12829.43% | -2681.17% | -7138.98% | | Repaid & issued | - | - | - | - | - | | CapEx | -820000.00 | -458000.00 | -863000.00 | -3.20M | -1.24M |